sefulness of Homoeopathy in the Treatment of urinary tract stones.
- Conditions
- Health Condition 1: N20-N23- Urolithiasis
- Registration Number
- CTRI/2023/08/056290
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients diagnosed with urolithiasis (by radiological evidence: Ultrasonography of
lower abdomen/K.U.B/C.T/M.R.I etc.)
2.Patients between 20-70 years of age, all religions, all socio-economic status.
3.All sexes, genders, races.
4.Patients who are on lifesaving conventional drug therapies (e,g antidiabetics,
antihypertensives, thyroid drugs)to be continued uninterrupted.
6.Patients who are willing to give written consent to participate in the study.
1. Diagnosed cases of unstable mental or psychiatric illness.
2.Patients who are suffering from any life-threatening illness or other uncontrolled
systemic disease affecting quality of life or any other vital organ.
3.Patients who are suffering from any major complication, Congenital Anomalies of
Kidney and the Urinary Tract, severe hydronephrosis.
4.Patients who are on active treatment from any other system of medicine.
5.Patients not willing to give consent for participation in the study.
6.Patients not willing to undergo any investigation if advised.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome: Urolithiasis Symptom Score (USS score) <br/ ><br>On the basis of score obtained from USS index chart, cases according to intensity <br/ ><br>will be grouped into mild (1-7), moderate (8-14) and severe (15-22). The scores of the initial <br/ ><br>and follow ups will be compared.Timepoint: Baseline,3rd and 6th month of treatment
- Secondary Outcome Measures
Name Time Method ltrasonography of KUB region at baseline,3 <br/ ><br>rd and 6th month of treatment will be <br/ ><br>done to assess/compare the number, size and location of the calculus/calculi. <br/ ><br>Timepoint: Baseline,3rd and 6th month of treatment